Story thread · 2 reports / 2 sources
Half of patients stop semaglutide within a year: 6 study notes
beckershospitalreview.com · 14d
How the coverage leans
Across 2 sources · syndicated copies counted once
Nearly half of adults who started semaglutide (Ozempic, Wegovy) for obesity management discontinued treatment within 12 months, a nationwide cohort study found. Researchers analyzed 157,822 first-time semaglutide users without diabetes in Denmark between Dec. 1, 2022, and Nov. 1, 2024, according to the study, published Aug. 28 in JAMA Network Open. The 12-month risk of […] The post Half of patients stop semaglutide within a year: 6 study notes appeared first on Becker's Hospital Review | Healthcare News & Analysis .
First report: About a Quarter of Those Who Stop Wegovy Start Again — medpagetoday.com, 17d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.